Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
Background & Aims
The antiviral function of peripheral hepatitis B virus (HBV)-specific T cells can be increased in patients with chronic hepatitis B by blocking the interaction of programmed death (PD)-1 with its ligand PD-L1. However, no information is available about the effects of this blockade on intrahepatic lymphocytes. We studied T-cell exhaustion and the effects of PD-1/PD-L1 blockade on intrahepatic and circulating HBV-specific T cells in patients with chronic hepatitis B.
Methods
A total of 42 patients with chronic HBV infection who underwent liver biopsy were studied. The ex vivo phenotype of peripheral and intrahepatic HBV-specific CD8+ T cells was assessed by flow cytometry with class I tetramers and antibodies to T-cell differentiation molecules. Functional recovery was evaluated by analyzing expansion and production of interferon (IFN)-γ and interleukin (IL)-2 after short-term incubation of T cells with HBV peptides in the presence of anti-PD-L1 or control antibodies.
Results
Intrahepatic HBV-specific CD8+ cells expressed higher levels of PD-1 and lower levels of CD127 than their peripheral counterparts. Blockade of PD-1/PD-L1 interaction increased CD8+ cell proliferation and IFN-γ and IL-2 production by circulating intrahepatic lymphocytes, even though anti-PD-L1 had a stronger effect on intrahepatic compared with peripheral T cells.
Conclusions
T-cell exhaustion by high antigen concentrations promotes HBV-specific T-cell dysfunction by affecting phenotype and function of peripheral and intrahepatic T cells. By restoring antiviral T-cell functions, not only in peripheral but also in intrahepatic lymphocytes, anti-PD-L1 might be a good therapeutic candidate for chronic HBV infection.
Abbreviations used in this paper: AA, amino acids, APC, allophycocyanin, CMV, cytomegalovirus, CTLA-4, cytotoxic T-lymphocyte-associated antigen-4, FITC, fluorescein isothiocyanate, FLU, influenza, IFN, interferon, IL, interleukin, LIL, liver infiltrating lymphocytes, PBMC, peripheral blood mononuclear cells, PCR, polymerase chain reaction, PD-1, programmed death-1, PD-L, PD-ligand, PE, phycoerythrin, PerCP, peridin chlorophyll protein
To access this article, please choose from the options below
Conflicts of interest The authors disclose no conflicts.
Funding Supported by the VIRGIL EC grant QLK2-CT-2002-00700; by Fondazione Cassa Risparmio di Parma, Parma, Italy; by grant 85/2007, Ricerca Finalizzata, Progetto Ordinario, Ministry of Health, Italy; and by Fondo per gli Investimenti della Ricerca di Base (grant No. RBNE013PMJ); and by the Ministry of Instruction, University and Research, Italy.
PII: S0016-5085(09)01747-8
doi:10.1053/j.gastro.2009.09.052
© 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

